Can-Fite BioPharma Ltd.: cashflow_investing
| Value | {"amount": -14511000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | Can-Fite BioPharma Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:35:01.962698+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6a5cb6fd-44bd-450b-aed4-f2ae7f435791
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-22-014672Retrieved: 2026-08-19T15:35:01.962698+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001536196/cashflow-investing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6a5cb6fd-44bd-450b-aed4-f2ae7f435791
History
- no predecessors — first report